Mangin D, Puel F, Veesler S. Polymorphism in processes of crystallization in solution: a practical review [J]. Organic Process Research & Development, 2009, 13 (6): 1241-1253.
[2]
Sharma P, Zujovic Z D, Bowmaker G A, Denny W A, Garg S. Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies [J]. International Journal of Pharmaceutics, 2011, 408 (1): 138-151.
[3]
Jiang Shanfeng, Jansens P J, ter Horst J H. Control over polymorph formation of o-aminobenzoic acid [J]. Crystal Growth & Design, 2010, 10 (6): 2541-2547.
[4]
Martínez-Ohárriz M C, Martin C, Goni M M, Rodríguez- Espinosa C, Ilarduya-Apaolaza D, Tros M C, Sánchez M. Polymorphism of diflunisal: isolation and solid-state characteristics of a new crystal form [J]. Journal of Pharmaceutical Sciences, 1994, 83 (2): 174-177.
[5]
Kralj D, Bre?evi? L, Nielsen A E. Vaterite growth and dissolution in aqueous solution (Ⅰ): Kinetics of crystal growth [J]. Journal of Crystal Growth, 1990, 104 (4): 793- 800.
[6]
Jiang Shanfeng, Jansens P J, ter Horst J H. Mechanism and kinetics of the polymorphic transformation of o- aminobenzoic acid [J]. Crystal Growth & Design, 2010, 10 (5): 2123-2128.
[7]
Nath N K, Aggarwal H, Nangia A. Crystal structure of methyl paraben polymorph Ⅱ [J]. Crystal Growth & Design, 2011, 11 (4): 967-971.
[8]
Roy S, Bhatt P M, Nangia A, Kruger G J. Stable polymorph of venlafaxine hydrochloride by solid-to-solid phase transition at high temperature [J]. Crystal Growth & Design, 2007, 7 (3): 476-480.
[9]
Mo Yuxin, Dang Leping, Wei Hongyuan. L-Glutamic acid polymorph control using amino acid additives [J]. Industrial & Engineering Chemistry Research, 2011, 50 (18): 10385-10392.
[10]
Price C P, Grzesiak A L, Matzger A J. Crystalline polymorph selection and discovery with polymer heteronuclei [J]. Journal of the American Chemical Society, 2005, 127 (15): 5512-5517.
[11]
McKellar S C, Urquhart A J, Lamprou D A, Florence A J. Polymer templating of supercooled indomethacin for polymorph selection [J]. ACS Combinatorial Science, 2012, 14 (3): 155-159.
[12]
Croker D, Hodnett B K. Mechanistic features of polymorphic transformations: the role of surfaces [J]. Crystal Growth & Design, 2010, 10 (6): 2806-2816.
[13]
Doki N, Seki H, Takano K, Asatani H, Yokota M, Kubota N. Process control of seeded batch cooling crystallization of the metastable α-form glycine using an in-situ ATR- FTIR spectrometer and an in-situ FBRM particle counter [J]. Crystal Growth & Design, 2004, 4 (5): 949-953.
[14]
Hausman D S, Cambron R T, Sakr A. Application of on-line Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability [J]. International Journal of Pharmaceutics, 2005, 299 (1): 19-33.
[15]
Braun D E, Karamertzanis P G, Arlin J B, Florence A J, Kahlenberg V, Tocher D A, Price S L. Solid-state forms of β-resorcylic acid: how exhaustive should a polymorph screen be? [J]. Crystal Growth & Design, 2010, 11 (1): 210-220.
[16]
Kawashima Y, Okumura M, Takenaka H. Spherical crystallization: direct spherical agglomeration of salicylic acid crystals during crystallization [J]. Science, 1982, 216 (4550): 1127-1128.
[17]
Zhang Haitao, Chen Ying, Wang Jingkang, Gong Junbo. Investigation on the spherical crystallization process of cefotaxime sodium [J]. Industrial & Engineering Chemistry Research, 2009, 49 (3): 1402-1411.
[18]
Kawashima Y, Aoki S, Takenaka H, Miyake Y. Preparation of spherically agglomerated crystals of aminophylline [J]. Journal of Pharmaceutical Sciences, 1984, 73 (10): 1407-1410.
[19]
Kawashima Y, Niwa T, Handa T, Takeuchi H, Iwamoto T, Itoh K. Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method [J]. Journal of Pharmaceutical Sciences, 1989, 78 (1): 68-72.
[20]
Nocent M, Bertocchi L, Espitalier F, Baron M, Couarraze G. Definition of a solvent system for spherical crystallization of salbutamol sulfate by quasi-emulsion solvent diffusion (QESD) method [J]. Journal of Pharmaceutical Sciences, 2001, 90 (10): 1620-1627.
[21]
Ueda M, Nakamura M Y, Makita H, Imasato Y, Kawashima Y. Particle design of enoxacin by spherical crystallization technique [J]. Chem. Pharm. Bull., 1990, 38 (9): 2537-2541.
[22]
Kawashima Y, Handa T, Takeuchi H. Crystal modification of phenytoin with polyethylene glycol for improving mechanical strength, dissolution rate and bioavailability by a spherical crystallization technique [J]. Chemical & Pharmaceutical Bulletin, 1986, 34 (8): 3376-3383.
[23]
Puechagut H G, Bianchotti J, Chiale C A. Preparation of norfloxacin spherical agglomerates using the ammonia diffusion system [J]. Journal of Pharmaceutical Sciences, 1998, 87 (4): 519-523.
[24]
Pawar A P, Paradkar A R, Kadam S S, Mahadik K R. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen- paracetamol agglomerates [J]. AAPS Pharm. Sci. Tech., 2004, 5 (3): 57-64.
